Premium
Results of Treatment with Pollen Extract (Cernilton R N) in Chronic Prostatitis and Prostatodynia
Author(s) -
RUGENDORFF E. W.,
WEIDNER W.,
EBELING L.,
BUCK A. C.
Publication year - 1993
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1993.tb15988.x
Subject(s) - medicine , prostatitis , urology , urine , prostate , massage , rectal examination , urinalysis , gastroenterology , surgery , pathology , alternative medicine , cancer
Summary— We report the results of a prospective study with the pollen extract, Cernilton R N, in a dose of 1 tablet tid for 6 months for the treatment of chronic prostatitis syndrome in 90 patients. The factors documented before and after 3 and 6 months' treatment were digital rectal examination (DRE) of the prostate, uroflowmetry, bacterial studies, leucocyte counts in urine and measurement of complement C3/coeruloplasmin in the seminal fluid. The patients were divided into 2 groups: those without associated complicating factors (CFs) (n = 72) and those with complicating factors, i.e. urethral strictures, prostatic calculi, bladder neck sclerosis (n = 18). In the group without CFs, 56 (78%) had a favourable response; 26 (36%) were cured of their symptoms and signs and 30 (42%) improved significantly with an increase in flow rate, a reduction in leucocyturia in the post–prostate massage urine (VB3) and a decrease in complement C3/coeruloplasmin in the ejaculate. In the patients with CFs only 1 patient showed a response. Complicating factors should be considered in patients who fail to respond to treatment within 3 months. Cernilton R N was well tolerated by 97% of patients.